These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17563087)

  • 1. Will knowledge of human genome variation result in changing cancer paradigms?
    Gottlieb B; Beitel LK; Trifiro M
    Bioessays; 2007 Jul; 29(7):678-85. PubMed ID: 17563087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the human genome and the inherited basis of common disease.
    Gabriel S
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S46-9. PubMed ID: 17178287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using germ-line genetic variation to investigate and treat cancer.
    Savage SA; Chanock SJ
    Drug Discov Today; 2004 Jul; 9(14):610-8. PubMed ID: 15239980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells.
    Park JJ; Kang JK; Hong S; Ryu ES; Kim JI; Lee JH; Seo JS
    Gene; 2008 Jan; 407(1-2):139-47. PubMed ID: 17997235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-epigenome interactions in cancer.
    Brena RM; Costello JF
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R96-105. PubMed ID: 17613554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5. Genetics of allergic disease.
    Steinke JW; Rich SS; Borish L
    J Allergy Clin Immunol; 2008 Feb; 121(2 Suppl):S384-7; quiz S416. PubMed ID: 18241687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding cancer at the chromosome level: 40 years of progress.
    Debernardi S; Lillington D; Young BD
    Eur J Cancer; 2004 Sep; 40(13):1960-7. PubMed ID: 15315804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pigmentation variation: evolution, genetic basis, and implications for public health.
    Parra EJ
    Am J Phys Anthropol; 2007; Suppl 45():85-105. PubMed ID: 18046745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and cancer--new paradigms in molecular oncology.
    Negrini M; Nicoloso MS; Calin GA
    Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of cancer chromosomes and genomes.
    Ye CJ; Liu G; Bremer SW; Heng HH
    Cytogenet Genome Res; 2007; 118(2-4):237-46. PubMed ID: 18000376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct molecular analysis of single disseminated cancer cells: a prerequisite for the development of adjuvant therapies?].
    Klein CA
    Acta Med Austriaca Suppl; 2002; 59():10-3. PubMed ID: 12506754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes.
    Sjöblom T
    Curr Opin Oncol; 2008 Jan; 20(1):66-71. PubMed ID: 18043258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-mammalian models for epigenetic analyses in cancer.
    Schaefer M; Meusburger M; Lyko F
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R1-6. PubMed ID: 17613542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
    Stindl R
    Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancers exhibit a mutator phenotype: clinical implications.
    Loeb LA; Bielas JH; Beckman RA
    Cancer Res; 2008 May; 68(10):3551-7; discussion 3557. PubMed ID: 18483233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species in tumor metastasis.
    Nishikawa M
    Cancer Lett; 2008 Jul; 266(1):53-9. PubMed ID: 18362051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.